Showing 521 - 540 results of 30,087 for search '(( 50 ((nn decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 12 mg decrease ))', query time: 0.79s Refine Results
  1. 521
  2. 522
  3. 523

    Fig 4 - by Duyan Geng (12072181)

    Published 2022
    Subjects:
  4. 524

    Fig 6 - by Duyan Geng (12072181)

    Published 2022
    Subjects:
  5. 525

    Fig 5 - by Duyan Geng (12072181)

    Published 2022
    Subjects:
  6. 526
  7. 527
  8. 528
  9. 529

    Transaldolase deficiency causes a starvation-like response that decreases animal fat content and rewires lipid metabolism gene expression. by Christopher F. Bennett (3875731)

    Published 2017
    “…<p><b>(A)</b> Intestinal fat staining decreases from RNAi knockdown of <i>tald-1</i> or <i>cco-1</i>. …”
  10. 530
  11. 531
  12. 532
  13. 533
  14. 534
  15. 535

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
  16. 536
  17. 537
  18. 538

    Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

    Published 2011
    “…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
  19. 539
  20. 540